Balance Sheet ASP Isotopes Inc.

Equities

ASPI

US00218A1051

Pharmaceuticals

End-of-day quote Nasdaq Other stock markets 2026-01-12			5-day change	1st Jan Change
7.490 ^USD	-0.27%		+14.53%	+40.00%

Dec. 30	ASX Midday Sector Update: Energy Stocks Climb, Real Estate Struggles	MT
Dec. 30	Renergen Securities Suspended From Quotation	MT

39a0fa7ba899a1.rfT9A6nkf28wfTz3l5JMhQtn1cXgshjMw2PSSJ3daL0._8C0SO-uMjtaT2iz3uE88k8zlPap5n2g8DCHG-2bP8yUkJRP5qgnAkEydQ

Published financial data: ASP ISOTOPES INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024
Revenues	-	-	433K	4.14M
Total Revenues	-	-	433K	4.14M
Cost of Goods Sold, Total	-	-	294K	2.54M
Gross Profit	-	-	139K	1.6M
Selling General & Admin Expenses, Total	7.7M	3.83M	15.42M	24.81M
R&D Expenses	125K	1.27M	765K	3.14M
Other Operating Expenses, Total	7.82M	5.1M	16.18M	27.95M
Operating Income	-7.82M	-5.1M	-16.04M	-26.35M
Interest Expense, Total	-	-	-119K	-259K
Interest And Investment Income	345	3.38K	9.07K	1.24M
Net Interest Expenses	345	3.38K	-109K	980K
Currency Exchange Gains (Loss)	-	-	45.75K	69.86K
Other Non Operating Income (Expenses)	-	151K	-195K	-7.01M
EBT, Excl. Unusual Items	-7.82M	-4.95M	-16.3M	-32.31M
EBT, Incl. Unusual Items	-7.82M	-4.95M	-16.3M	-32.31M
Income Tax Expense	-	-	-6.13K	111K
Earnings From Continuing Operations	-7.82M	-4.95M	-16.29M	-32.42M
Net Income to Company	-7.82M	-4.95M	-16.29M	-32.42M
Minority Interest	-	-	7.89K	89.15K
Net Income - (IS)	-7.82M	-4.95M	-16.29M	-32.33M
Preferred Dividend and Other Adjustments	-	-	-	2.78M
Net Income to Common Incl Extra Items	-7.82M	-4.95M	-16.29M	-35.11M
Net Income to Common Excl. Extra Items	-7.82M	-4.95M	-16.29M	-35.11M
Per Share Items
Net EPS - Basic	-0.48	-0.18	-0.49	-0.63
Basic EPS - Continuing Operations	-0.48	-0.18	-0.49	-0.63
Basic Weighted Average Shares Outstanding	16.25M	26.79M	33.07M	55.67M
Net EPS - Diluted	-0.48	-0.18	-0.49	-0.63
Diluted EPS - Continuing Operations	-0.48	-0.18	-0.49	-0.63
Diluted Weighted Average Shares Outstanding	16.25M	26.79M	33.07M	55.67M
Normalized Basic EPS	-0.3	-0.12	-0.31	-0.36
Normalized Diluted EPS	-0.3	-0.12	-0.31	-0.36
Supplemental Items
EBITDA	-	-	-16M	-25.88M
EBITA	-7.82M	-5.1M	-16.04M	-26.35M
EBIT	-7.82M	-5.1M	-16.04M	-26.35M
EBITDAR	-	-	-15.83M	-25.22M
Total Revenues (As Reported)	-	-	-	4.14M
Effective Tax Rate - (Ratio)	-	-	0.04	-0.34
Current Domestic Taxes	-	-	-	61.74K
Current Foreign Taxes	-	-	-	193K
Total Current Taxes	-	-	-	255K
Deferred Foreign Taxes	-	-	-	-143K
Total Deferred Taxes	-	-	-	-143K
Normalized Net Income	-4.89M	-3.09M	-10.18M	-20.11M
Interest on Long-Term Debt	-	-	5.06K	140K
Supplemental Operating Expense Items
General and Administrative Expenses	7.7M	3.83M	15.42M	24.81M
Research And Development Expense From Footnotes	125K	1.27M	765K	3.14M
Net Rental Expense, Total	36.37K	126K	179K	664K
Imputed Operating Lease Interest Expense	-	-	114K	68.91K
Imputed Operating Lease Depreciation	-	-	64.34K	595K
Stock-Based Comp., R&D Exp. (Total)	-	201K	365K	330K
Stock-Based Comp., G&A Exp. (Total)	6.75M	1.8M	8.38M	8.23M
Stock-Based Comp., Other (Total)	-	50K	670K	1.31M
Total Stock-Based Compensation	6.75M	2.05M	9.41M	9.88M

Fiscal Period: December	2021	2022	2023	2024
Assets
Cash And Equivalents	2.95M	2.39M	7.91M	61.89M
Total Cash And Short Term Investments	2.95M	2.39M	7.91M	61.89M
Accounts Receivable, Total	-	-	217K	707K
Other Receivables	-	-	722K	27.56K
Total Receivables	-	-	938K	734K
Inventory	-	-	-	65.66K
Prepaid Expenses	268K	913K	1.66M	3.05M
Total Current Assets	3.22M	3.3M	10.51M	65.74M
Gross Property Plant And Equipment	-	9.05M	12.01M	23.96M
Accumulated Depreciation	-	-	-37.71K	-486K
Net Property Plant And Equipment	3.92M	9.05M	11.97M	23.48M
Goodwill	-	-	3.27M	3.17M
Deferred Tax Assets Long-Term	-	-	-	31.85K
Other Long-Term Assets, Total	-	140K	1.79M	1.93M
Total Assets	7.14M	12.5M	27.54M	94.35M
Liabilities
Accounts Payable, Total	59.68K	1.35M	1.11M	1.02M
Accrued Expenses, Total	42.5K	361K	1.31M	2.28M
Short-term Borrowings	46.9K	33.85K	470K	-
Current Portion of Long-Term Debt	-	-	-	939K
Current Portion of Leases	38.07K	45.9K	399K	684K
Unearned Revenue Current, Total	-	-	882K	882K
Other Current Liabilities	116K	140K	1.5M	1.26M
Total Current Liabilities	303K	1.94M	5.67M	7.06M
Long-Term Debt	-	-	-	34.87M
Long-Term Leases	842K	742K	1.27M	1.25M
Deferred Tax Liability Non Current	-	-	111K	-
Other Non Current Liabilities	-	-	1.65M	-
Total Liabilities	1.14M	2.68M	8.71M	43.18M
Common Stock, Total	207K	359K	489K	721K
Additional Paid In Capital	8.38M	16.76M	40.57M	106M
Retained Earnings	-2.61M	-7.55M	-23.84M	-56.17M
Comprehensive Income and Other	18.72K	255K	-921K	-2.16M
Total Common Equity	6M	9.82M	16.3M	47.9M
Minority Interest	-	-	2.53M	3.27M
Total Equity	6M	9.82M	18.83M	51.17M
Total Liabilities And Equity	7.14M	12.5M	27.54M	94.35M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	20.65M	37.39M	48.6M	72.07M
ECS Total Common Shares Outstanding	20.65M	35.91M	48.92M	72.07M
Book Value / Share	0.29	0.27	0.33	0.66
Tangible Book Value	6M	9.82M	13.03M	44.73M
Tangible Book Value Per Share	0.29	0.27	0.27	0.62
Total Debt	927K	822K	2.14M	37.75M
Net Debt	-2.03M	-1.57M	-5.77M	-24.14M
Debt Equivalent Oper. Leases	-	1.01M	1.43M	5.31M
Minority Interest, Total (Incl. Fin. Div)	-	-	2.53M	3.27M
Account Code - Inventory Valuation	3	3	3	5
Machinery, Total	-	-	1.62M	8.75M
Full Time Employees	-	4	76	136

Fiscal Period: December	2021	2022	2023	2024
Net Income	-7.82M	-4.95M	-16.29M	-32.33M
Depreciation & Amortization - CF	58.13K	72.57K	142K	945K
Depreciation & Amortization, Total	58.13K	72.57K	142K	945K
(Gain) Loss From Sale Of Asset	-	-	-	1.67K
Stock-Based Compensation (CF)	6.75M	2.05M	9.41M	9.88M
Other Operating Activities, Total	-	-151K	159K	7.44M
Change In Accounts Receivable	-	-	238K	-506K
Change In Inventories	-	-	-	-67.64K
Change In Accounts Payable	179K	571K	-225K	-877K
Change in Unearned Revenues	-	-	882K	-
Change In Income Taxes	-	-	-22.79K	-
Change in Other Net Operating Assets	-894K	-537K	287K	-1.17M
Cash from Operations	-1.73M	-2.94M	-5.41M	-16.7M
Capital Expenditure	-8.96M	-4.47M	-2.33M	-11.37M
Cash Acquisitions	-	-	-122K	-
Cash from Investing	-8.96M	-4.47M	-2.45M	-11.37M
Short Term Debt Issued, Total	46.9K	-	526K	501K
Long-Term Debt Issued, Total	-	-	-	25.94M
Total Debt Issued	141K	-	526K	26.44M
Short Term Debt Repaid, Total	-	-13.05K	-697K	-561K
Long-Term Debt Repaid, Total	-	-	-9.6K	-152K
Total Debt Repaid	-	-13.05K	-707K	-713K
Issuance of Common Stock	20.04M	8.12M	14.13M	58.93M
Other Financing Activities, Total	-678K	-1.47M	-563K	-2.12M
Cash from Financing	19.5M	6.64M	13.39M	82.53M
Foreign Exchange Rate Adjustments	56.17K	207K	-867	-484K
Net Change in Cash	8.86M	-565K	5.52M	53.98M
Supplemental Items
Levered Free Cash Flow	-	-4.55M	-1.62M	-17.81M
Unlevered Free Cash Flow	-	-4.55M	-1.54M	-17.64M
Change In Net Working Capital	-	-993K	-1.26M	621K
Net Debt Issued / Repaid	141K	-13.05K	-181K	25.72M

Fiscal Period: December	2021	2022	2023	2024
Profitability
Return on Assets	-	-32.46	-50.08	-27.03
Return on Total Capital	-	-36.29	-63.43	-29.98
Return On Equity %	-	-62.54	-113.75	-92.64
Return on Common Equity	-	-62.54	-124.73	-109.4
Margin Analysis
Gross Profit Margin %	-	-	32.09	38.6
SG&A Margin	-	-	3.56K	598.77
EBITDA Margin %	-	-	-3.7K	-624.54
EBITA Margin %	-	-	-3.7K	-635.91
EBIT Margin %	-	-	-3.7K	-635.91
Income From Continuing Operations Margin %	-	-	-3.76K	-782.36
Net Income Margin %	-	-	-3.76K	-780.21
Net Avail. For Common Margin %	-	-	-3.76K	-847.28
Normalized Net Income Margin	-	-	-2.35K	-485.14
Levered Free Cash Flow Margin	-	-	-373.38	-429.66
Unlevered Free Cash Flow Margin	-	-	-356.27	-425.75
Asset Turnover
Asset Turnover	-	-	0.02	0.07
Fixed Assets Turnover	-	-	0.04	0.23
Receivables Turnover (Average Receivables)	-	-	-	8.98
Short Term Liquidity
Current Ratio	10.62	1.71	1.85	9.31
Quick Ratio	9.74	1.23	1.56	8.87
Operating Cash Flow to Current Liabilities	-5.71	-1.52	-0.95	-2.37
Days Sales Outstanding (Average Receivables)	-	-	-	40.78
Average Days Payable Outstanding	-	-	1.53K	-
Long Term Solvency
Total Debt/Equity	15.45	8.37	11.38	73.77
Total Debt / Total Capital	13.38	7.73	10.22	42.45
LT Debt/Equity	14.03	7.56	6.76	70.6
Long-Term Debt / Total Capital	12.15	6.98	6.07	40.63
Total Liabilities / Total Assets	16.03	21.44	31.63	45.77
EBIT / Interest Expense	-	-	-135.32	-101.8
EBITDA / Interest Expense	-	-	-133.5	-97.42
(EBITDA - Capex) / Interest Expense	-	-	-153.17	-141.35
Total Debt / EBITDA	-	-0.17	-0.14	-1.5
Net Debt / EBITDA	-	0.32	0.36	0.96
Total Debt / (EBITDA - Capex)	-	-0.09	-0.12	-1.03
Net Debt / (EBITDA - Capex)	-	0.17	0.32	0.66
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	857.04
Gross Profit, 1 Yr. Growth %	-	-	-	1.05K
EBITDA, 1 Yr. Growth %	-	-	-	61.72
EBITA, 1 Yr. Growth %	-	-34.83	214.61	64.28
EBIT, 1 Yr. Growth %	-	-34.83	214.61	64.28
Earnings From Cont. Operations, 1 Yr. Growth %	-	-36.79	229.5	98.98
Net Income, 1 Yr. Growth %	-	-36.79	229.34	98.53
Normalized Net Income, 1 Yr. Growth %	-	-36.79	229.37	97.5
Diluted EPS Before Extra, 1 Yr. Growth %	-	-61.67	166.86	28.06
Accounts Receivable, 1 Yr. Growth %	-	-	-	226.52
Net Property, Plant and Equip., 1 Yr. Growth %	-	130.9	32.22	96.1
Total Assets, 1 Yr. Growth %	-	74.95	120.4	242.56
Tangible Book Value, 1 Yr. Growth %	-	63.69	32.71	243.32
Common Equity, 1 Yr. Growth %	-	63.69	65.99	193.93
Cash From Operations, 1 Yr. Growth %	-	69.63	84.1	208.47
Capital Expenditures, 1 Yr. Growth %	-	-50.1	-47.88	387.8
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-64.43	1K
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-66.06	1.04K
Compound Annual Growth Rate Over Two Years
EBITA, 2 Yr. CAGR %	-	-	43.19	127.34
EBIT, 2 Yr. CAGR %	-	-	43.19	127.34
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	44.31	156.06
Net Income, 2 Yr. CAGR %	-	-	44.28	155.7
Normalized Net Income, 2 Yr. CAGR %	-	-	44.28	155.05
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	1.13	84.86
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	74.73	61.02
Total Assets, 2 Yr. CAGR %	-	-	96.37	174.77
Tangible Book Value, 2 Yr. CAGR %	-	-	47.39	113.45
Common Equity, 2 Yr. CAGR %	-	-	64.83	120.88
Cash From Operations, 2 Yr. CAGR %	-	-	76.72	138.3
Capital Expenditures, 2 Yr. CAGR %	-	-	-49	59.45
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	97.92
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	97.02
Compound Annual Growth Rate Over Three Years
EBITA, 3 Yr. CAGR %	-	-	-	49.9
EBIT, 3 Yr. CAGR %	-	-	-	49.9
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	60.62
Net Income, 3 Yr. CAGR %	-	-	-	60.48
Normalized Net Income, 3 Yr. CAGR %	-	-	-	60.2
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	9.41
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	81.58
Total Assets, 3 Yr. CAGR %	-	-	-	136.39
Tangible Book Value, 3 Yr. CAGR %	-	-	-	95.38
Common Equity, 3 Yr. CAGR %	-	-	-	99.88
Cash From Operations, 3 Yr. CAGR %	-	-	-	112.78
Capital Expenditures, 3 Yr. CAGR %	-	-	-	8.25